CERO – cero therapeutics holdings, inc. (US:NASDAQ)
Stock Stats
News
CERo Therapeutics Announces Trading on OTCQB Market
Aggressive cancer warning signs revealed after JFK's granddaughter's diagnosis [FOX News]
CERo Therapeutics (NASDAQ:CERO) was downgraded by analysts at D Boral Capital from a "strong-buy" rating to a "hold" rating.
CERo Therapeutics (NASDAQ:CERO) had its "hold" rating reaffirmed by analysts at D. Boral Capital.
CERo Therapeutics Initiates Second Cohort of Phase 1 Clinical Trial of CER-1236 in AML with Patient Receiving Significant Increase in Dosing
Form 424B3 CERO THERAPEUTICS HOLDIN
Form 424B3 CERO THERAPEUTICS HOLDIN
Form DEFA14A CERO THERAPEUTICS HOLDIN
Form 8-K CERO THERAPEUTICS HOLDIN For: Nov 26
Form DEF 14A CERO THERAPEUTICS HOLDIN For: Dec 19
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.